Literature DB >> 18339726

Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging.

S J P M van Engelen1, L C Krab, H A Moll, A de Goede-Bolder, S M F Pluijm, C E Catsman-Berrevoets, Y Elgersma, M H Lequin.   

Abstract

BACKGROUND AND
PURPOSE: Hyperintensities on T2-weighted images are seen in the brains of most patients with neurofibromatosis type I (NF-1), but the origin of these unidentified bright objects (UBOs) remains obscure. In the current study, we examined the diffusion characteristics of brain tissue in children with NF-1 to test the hypothesis that a microstructural abnormality is present in NF-1.
MATERIALS AND METHODS: Diffusion tensor imaging (DTI) was performed in 50 children with NF-1 and 8 controls. Circular regions of interest were manually placed in 7 standardized locations in both hemispheres, including UBO sites. Apparent diffusion coefficients (ADC), fractional anisotropy (FA), and axial anisotropy (A(m)) were used to differentiate quantitatively between healthy and disordered brain matter. Differences in eigenvalues (lambda(1), lambda(2), lambda(3)) were determined to examine parenchymal integrity.
RESULTS: We found higher ADC values for UBOs than for normal-appearing sites (P < .01) and higher ADC values for normal-appearing sites than for controls (P < .04 in 5 of 7 regions). In most regions, we found no differences in FA or A(m). Eigenvalues lambda(2) and lambda(3) were higher at UBO sites than in normal-appearing sites (P < .04).
CONCLUSION: With ADC, it was possible to differentiate quantitatively between normal- and abnormal-appearing brain matter in NF-1 and also between normal-appearing brain matter in NF-1 and healthy brain matter in controls, indicating subtle pathologic damage disrupting the tissue microstructure in the NF-1 brain. Higher diffusivity for lambda(1), lambda(2), and lambda(3) indicates that this disturbance of microstructure is caused by accumulation of fluid or vacuolation.

Entities:  

Mesh:

Year:  2008        PMID: 18339726      PMCID: PMC7978201          DOI: 10.3174/ajnr.A0921

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  29 in total

1.  From the diffusion coefficient to the diffusion tensor.

Authors:  Denis Le Bihan; Peter van Zijl
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

2.  Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1.

Authors:  J D Eastwood; D J Fiorella; J F MacFall; D M Delong; J M Provenzale; R S Greenwood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

3.  Differentiation of dys- and demyelination using diffusional anisotropy.

Authors:  J Ono; K Harada; T Mano; K Sakurai; S Okada
Journal:  Pediatr Neurol       Date:  1997-01       Impact factor: 3.372

4.  Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging.

Authors:  J J Neil; S I Shiran; R C McKinstry; G L Schefft; A Z Snyder; C R Almli; E Akbudak; J A Aronovitz; J P Miller; B C Lee; T E Conturo
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

Review 5.  Diffusion-weighted imaging in tissues: theoretical models.

Authors:  A Szafer; J Zhong; A W Anderson; J C Gore
Journal:  NMR Biomed       Date:  1995 Nov-Dec       Impact factor: 4.044

6.  Demyelination increases radial diffusivity in corpus callosum of mouse brain.

Authors:  Sheng-Kwei Song; Jun Yoshino; Tuan Q Le; Shiow-Jiuan Lin; Shu-Wei Sun; Anne H Cross; Regina C Armstrong
Journal:  Neuroimage       Date:  2005-05-15       Impact factor: 6.556

7.  Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation.

Authors:  Pratik Mukherjee; Jeffrey H Miller; Joshua S Shimony; Joseph V Philip; Deepika Nehra; Abraham Z Snyder; Thomas E Conturo; Jeffrey J Neil; Robert C McKinstry
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

8.  Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.

Authors:  Giuseppe Tognini; Francesco Ferrozzi; Giacomo Garlaschi; Paolo Piazza; Arianna Patti; Raffaele Virdis; Chiara Bertolino; Giancarlo Bertolino; Daniele Manfredini; Maurizio Zompatori; Girolamo Crisi
Journal:  J Comput Assist Tomogr       Date:  2005 May-Jun       Impact factor: 1.826

9.  Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1.

Authors:  S L Zamboni; T Loenneker; E Boltshauser; E Martin; K A Il'yasov
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

10.  Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1.

Authors:  F Menor; L Martí-Bonmatí; F Mulas; H Cortina; R Olagüe
Journal:  Pediatr Radiol       Date:  1991
View more
  24 in total

1.  Usefulness of diffusion tensor imaging and fiber tractography in neurological and neurosurgical pediatric diseases.

Authors:  Alberto Spalice; Francesco Nicita; Laura Papetti; Fabiana Ursitti; Claudio Di Biasi; Pasquale Parisi; Martino Ruggieri; Paola Iannetti
Journal:  Childs Nerv Syst       Date:  2010-06-16       Impact factor: 1.475

2.  Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1.

Authors:  E L Wignall; P D Griffiths; N G Papadakis; I D Wilkinson; L I Wallis; O Bandmann; P E E Cowell; N Hoggard
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

3.  Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1.

Authors:  Gulhan Ertan; Elcin Zan; David M Yousem; Can Ceritoglu; Aylin Tekes; Andrea Poretti; Thierry A G M Huisman
Journal:  Neuroradiol J       Date:  2014-09-25

4.  Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1.

Authors:  Camille Chabernaud; Maarten Mennes; Peter G Kardel; William D Gaillard; M Layne Kalbfleisch; John W Vanmeter; Roger J Packer; Michael P Milham; Francisco X Castellanos; Maria T Acosta
Journal:  Neurosci Lett       Date:  2012-03-13       Impact factor: 3.046

Review 5.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

6.  Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.

Authors:  José R L Ferraz-Filho; Antônio J da Rocha; Marcos P Muniz; Antônio S Souza; Eny M Goloni-Bertollo; Erika C Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2011-10-28

Review 7.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

8.  Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3T in children with neurofibromatosis type I (NF-1).

Authors:  Christopher G Filippi; Aaron Bos; Joshua P Nickerson; Michael B Salmela; Chris J Koski; Keith A Cauley
Journal:  Pediatr Radiol       Date:  2011-08-21

9.  Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex.

Authors:  Sahayini Arulrajah; Gulhan Ertan; Lori Jordan; Aylin Tekes; Elizabeth Khaykin; Izlem Izbudak; Thierry A G M Huisman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

10.  Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.

Authors:  Steffie N Tomson; Matthew J Schreiner; Manjari Narayan; Tena Rosser; Nicole Enrique; Alcino J Silva; Genevera I Allen; Susan Y Bookheimer; Carrie E Bearden
Journal:  Hum Brain Mapp       Date:  2015-08-25       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.